T1	intervention 55 87	interval and continuous exercise
T2	total-participants 252 261	Seventeen
T3	age 293 306	62.9Â±7.8years
T4	eligibility 262 285	female cancer survivors
T5	control 443 460	wait-list control
T6	intervention-participants 385 386	6
T7	intervention-participants 436 437	5
T8	control-participants 469 470	6
T9	outcome-Measure 575 624	cognitive function assessments utilising CogState
T11	total-participants 860 862	17
T12	outcome 938 947	adherence
T16	outcome 1342 1349	VO2peak
T13	iv-cont-mean 978 982	78.7
T20	iv-cont-sd 983 988	13.2%
T14	iv-cont-mean 992 996	79.4
T21	iv-cont-sd 997 1002	12.0%
T10	outcome-Measure 650 700	resting middle cerebral artery blood flow velocity
T17	outcome-Measure 702 728	cerebrovascular reactivity
T18	outcome-Measure 733 758	aerobic fitness (VO2peak)
T15	outcome 1208 1223	episodic memory
T19	outcome 1225 1239	working memory
T22	outcome 1241 1259	executive function
T23	outcome 1261 1280	cerebral blood flow
T24	outcome 1285 1311	cerebrovascular reactivity
T25	iv-cont-mean 1353 1358	19.3%
T26	iv-cont-mean 1398 1402	5.6%
T27	cv-cont-mean 1450 1454	2.6%
T28	outcome 1569 1590	cognitive performance
T29	outcome 1592 1616	cerebrovascular function
T30	outcome 1621 1636	aerobic fitness
